arrow_back Back to App

Insulin Price Cap: $25 Maximum Monthly Cost for Insured Patients.

This law sets a maximum out-of-pocket cost for insulin for most Americans covered by health insurance, including private group plans, individual coverage, and Medicare Part D. Starting in 2024, the maximum charge for a 30-day supply of selected insulin products cannot exceed $25, significantly reducing financial burdens for diabetic patients.
Key points
Cost Cap: Health plans cannot charge more than $25 for a 30-day supply of selected insulin products, or 25% of the negotiated price, whichever is lower, starting January 1, 2024.
No Deductibles: Health plans are prohibited from applying any deductible before covering the cost of selected insulin products.
Medicare Coverage: The $25 monthly cap on insulin costs is also applied to beneficiaries enrolled in Medicare Part D during 2024 and 2025.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_S_146
Sponsor: Sen. Hawley, Josh [R-MO]
Process start date: 2023-01-30
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-09-2025
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Cap Insulin Prices Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_S_146.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2023-01-30.

What are the main provisions?

Key points include:

  • Cost Cap: Health plans cannot charge more than $25 for a 30-day supply of selected insulin products, or 25% of the negotiated price, whichever is lower, starting January 1, 2024.
  • No Deductibles: Health plans are prohibited from applying any deductible before covering the cost of selected insulin products.
  • Medicare Coverage: The $25 monthly cap on insulin costs is also applied to beneficiaries enrolled in Medicare Part D during 2024 and 2025.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Hawley, Josh [R-MO].

What is the latest detailed status?

The latest detailed status is: Introduced in Senate

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-26.

CATEGORIES

Health